Buy Retatrutide Online

Peptara Labs sells retatrutide online as a 20mg research-grade vial, ordered from this page. Retatrutide is investigational, so no pharmacy stocks it and there is no prescription lane, compounded or otherwise: any source sells research-grade material, which makes the batch certificate the thing to compare.

One 20mg vial is $205 USD, which is $10.25 per mg. Signing up by email takes 15 percent off a first order, which brings a vial to $174. Buying more of the same compound lowers the per-vial price on that line, to 40 percent off at 10 vials, which is $123 each.

Yes. Orders to the United States, Canada, the United Kingdom and New Zealand ship tracked in 5 to 10 business days, guaranteed. Shipping is a flat $35, free over $250. US orders ship free in 2 to 3 days when every item ships from the US warehouse.

Before you buy, read certificate COA-2026-6928 for the released batch, lot RETA-260512-A: 99.18 percent purity by HPLC, identity by LC-MS at 4731.4 Da and 20.41 mg of net peptide, tested by Titreon Analytical, with an independent Janoshik endotoxin report on the same batch. The check that matters is a third-party Certificate of Analysis: every Peptara Labs Retatrutide vial ships with a batch COA confirming 98%+ purity and identity. That certificate is published online rather than printed on the vial, so after delivery your order number is what ties your vial to its batch: message it to us on WhatsApp and we will confirm the batch.

One sealed 20mg vial of lyophilized retatrutide and bacteriostatic water to reconstitute it, plus a printed reference guide to what published studies reported. The batch certificate is published on the certificates page, because the vial itself ships unlabeled.

No. There is no approved retatrutide product anywhere, so there is no prescription lane and no pharmacy lane, compounded or otherwise. Retatrutide is investigational, in phase 3 trials, and it reaches the market only as research-grade material sold for laboratory research use, not for human use.

Yes. "GLP-3" is an informal nickname for retatrutide, which is also shortened to "reta" online. There is no GLP-3 receptor: retatrutide is a single peptide that activates the GIP, GLP-1 and glucagon receptors together (Coskun et al., 2022), and Peptara Labs sells it under its proper name.

Retatrutide ships as a lyophilized, freeze-dried powder, which is stable at room temperature for weeks, so it travels without refrigeration. After reconstitution with bacteriostatic water the vial belongs in a refrigerator, and storage instructions are included with every order.

Yes. Peptara Labs is a registered business with responsive customer support via WhatsApp. Unlike anonymous Telegram sellers, we stand behind every order with our name, reputation, and ongoing support.

We're a team of expats and locals. We started Peptara Labs because sourcing quality research peptides was a mess: $500+ vials abroad, anonymous Telegram sellers, or overseas shipments that might not survive customs. So we built what we wished existed. Third-party tested material with a published certificate of analysis, fast delivery, and a team that answers every WhatsApp message about certificates, storage, shipping and orders. This isn't a faceless storefront.

Every Retatrutide vial comes with a third-party Certificate of Analysis (COA) confirming 98%+ purity. We source from verified manufacturers and can provide lab documentation upon request. If you want to see a COA before ordering, message us on WhatsApp and we'll send it over.

Trial by trial only, because the two have not been tested head to head. Tirzepatide is a dual GIP and GLP-1 agonist, and retatrutide adds glucagon to make three. SURMOUNT-1 reported a mean body-weight reduction of up to about 22.5 percent for tirzepatide (Jastreboff et al., 2022). The published phase 2 retatrutide trial reported a mean of up to about 24.2 percent at 48 weeks (Jastreboff et al., 2023), and Eli Lilly has since reported a phase 3 TRIUMPH-4 topline of about 28.7 percent at 68 weeks, pending peer review. Tirzepatide is FDA-approved; retatrutide is investigational and not approved by the FDA or any other regulator.

We offer a 60-day money back guarantee: verified purity, a certificate of analysis, and correct fulfillment, or your money back. It is a guarantee on the material and on how the order is handled, and on nothing else. Our team stays reachable on WhatsApp for questions about certificates, storage, shipping and orders.

Group means from named trials, and nothing beyond them. The published phase 2 trial reported a mean body-weight change of up to about 24.2 percent at 48 weeks, against about 2.1 percent on placebo (Jastreboff et al., 2023). Eli Lilly has since reported a phase 3 TRIUMPH-4 topline of about 28.7 percent at 68 weeks, pending peer-reviewed publication. Both are averages across a trial population under a controlled protocol, not a forecast beyond it.

It ran for 48 weeks, enrolled 338 adults and compared four retatrutide arms with placebo (Jastreboff et al., NEJM 2023; doi:10.1056/NEJMoa2301972). That trial is the published evidence base for retatrutide; phase 3 results, including Eli Lilly's TRIUMPH-4 topline, are still emerging.

LY3437943 is the development code for retatrutide. Coskun et al. (Cell Metabolism, 2022) described it as a single peptide that activates the glucagon, GIP and GLP-1 receptors together, which is why "triple agonist" is the accurate description.

Retatrutide activates the GLP-1, GIP and glucagon receptors at once. The literature describes GLP-1 receptor signaling as reducing hunger signaling and increasing satiety, GIP receptor signaling as modulating insulin response and lipid handling, and glucagon receptor signaling as raising thermogenesis and resting energy expenditure. Whether that combination outperforms a single or dual agonist has not been tested head to head.

Gastrointestinal effects were the most commonly reported adverse events in the published phase 2 trial (Jastreboff et al., 2023). Retatrutide is still investigational, so its long-term safety profile is not established, and it is not approved by the FDA or any other regulator.

With bacteriostatic water, which comes in the order. Peptara Labs defaults to 2 mL, which puts the 20mg in the vial at 10 mg per mL. The volume sets the concentration, never the amount of peptide in the vial. Once reconstituted, the vial belongs in a refrigerator, and storage instructions ship with every order.

You can. But you don't know what's in them, who made them, or how they were stored. Telegram sellers operate anonymously with no accountability. No COA. No real company behind them. No support if something goes wrong. Our price includes third-party testing, fast delivery, bacteriostatic water, COA access, and educational support. We don't just sell peptides. We make sure you get a verified, properly handled product you can trust.

Yes. We accept Visa, Mastercard and Amex cards, bank transfer, and USDT, USDC or BTC crypto. All transactions are handled securely. For bank transfers, you'll receive confirmation once payment is verified. Your financial information is never stored. If you have concerns about a specific payment method, message us and we'll find an option that works for you.

No. Retatrutide is investigational: as of 2026 it is in phase 3 trials and is not approved by the FDA, or any regulator, for any use. The published evidence base is the phase 2 trial (Jastreboff et al., 2023), with phase 3 results still emerging. Peptara Labs supplies it as research-grade material for laboratory use, not as a medicine, and nothing here is medical advice.